Fee income performed solidly in the fourth quarter. Fee revenue of $657 million was up 8% sequentially and 14% from the prior ...
Mediocre performance and high interest rates were the main culprits in 2024.
We think PNC stock is slightly pricey, and that investors considering this firm should wait for a better entry point.
CoinDesk Bitcoin Price Index is up $690.48 today or 0.69% to $100308.25 --Highest 4 p.m. level since Jan. 6, 2025, when it traded at $102258.56 --Best three day stretch since the three days ending Nov ...
During the hearing, Turner signaled that he would focus on regulatory reform to encourage home building. When pressed for more details by Sen. Tina Smith, a Minnesota Democrat, he said he planned to ...
The S&P 500 Index is down 12.57 points or 0.21% today to 5937.34 --Largest one-day point and percentage decline since Friday, Jan. 10, 2025 --Off 2.51% from its record close of 6090.27 hit Friday, Dec ...
Zoe Weber, who submitted a few examples of possible price gouging to the L.A. Tenants Union's spreadsheet, also sent text messages to agents and landlords, warning them that they could be violating ...
--Up 2.90% from its 2025 closing low of 41938.45 hit Friday, Jan. 10, 2025 --Month-to-date it is up 1.43% --Year-to-date it is up 608.91 points or 1.43% Inflation ticked higher overall, but stocks and ...
OTTAWA--Mark Carney, the former Canadian and U.K. central banker, formally declared Thursday his interest to succeed Justin Trudeau as leader of Liberal Party and the country's prime minister, ...
The Wall Street Journal had reported on a series of deceptive and strong-arm tactics the card company used to increase small business sign-ups. Morgan Stanley beats earnings expectations amid strength ...
"I can't imagine using someone's worst moment, where they've just lost everything and they're going through kind of a once-in-a-lifetime trauma, and to capitalize off of it and try and get more money ...
On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...